FOX GROUP, INC. v. Cree, Inc.

819 F. Supp. 2d 520, 2011 U.S. Dist. LEXIS 79019, 2011 WL 2963580
District Court, E.D. Virginia·Decided July 20, 2011·No. Action 2:10cv314·Published·Cited by 1 cases

Opinion

MEMORANDUM OPINION AND ORDER

REBECCA BEACH SMITH, District Judge.

This matter comes before the court on The Fox Group, Inc.’s (“Fox”) Motion for Entry of Partial Summary Judgment of Non-Infringement of U.S. Patent No. 6,543,026, and Dismissal Without Prejudice of Related Counterclaims, Based on the Court’s Claim Construction (“Fox’s Summary Judgment Motion”).

I. Factual and Procedural History

The relevant factual history and the relevant procedural history prior to June 10, 2011, is set forth in detail in this court’s claim construction Opinion, and need not be repeated herein. See The Fox Group, Inc. v. Cree, Inc., 819 F.Supp.2d 490, 494-97, 2011 WL 2308694, at *1-4 (E.D.Va. June 10, 2011).

On June 28, 2011, Fox filed its Summary Judgment Motion, in which it represents that it cannot prove that Cree, Inc. (“Cree”) infringed U.S. Patent No. 6,543,026 (“'026 patent”) under this court’s construction of the claims of that patent, and “based upon the discovery provided by Cree in this action.” Mem. in Supp. of Mot. for Summ. J. 1, ECF No. 383; see Compl. ¶¶ 18-25, ECF No. 1 (alleging Cree’s infringement of the '026 patent). Accordingly, Fox requests that the court enter ’partial summary judgment of non-infringement of the '026 patent in favor of Cree. Fox also requests that “the Court dismiss Cree’s counterclaims as moot or, in the alternative, decline to exercise declaratory judgment jurisdiction to hear Cree’s *522 counterclaims at this time.” Mem. in Supp. of Mot. for Summ. J. 7. On July 6, 2011, Cree filed its Partial Opposition to Fox’s Summary Judgment Motion. Cree “agrees that summary judgment of non-infringement with respect to the '026 patent is appropriate and should be entered in its favor,” Partial Opp. to Mot. for Summ. J. 1, ECF No. 430 [hereinafter “Cree’s Opp.”], but argues that the Court should exercise its discretion to hear Cree’s counterclaims that seek declarations that the '026 patent is invalid and unenforceable. See Answer ¶¶ 130-35, ECF No. 12. On July 14, 2011, Fox filed its Reply. Fox’s Summary Judgment Motion is ripe for review.

II. Analysis

Summary judgment is appropriate when a court, viewing the record as a whole and in the light most favorable to the nonmoving party, finds that there is no genuine issue of material fact and that the moving party is entitled to judgment as a matter of law. See Fed.R.Civ.P. 56(a); Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248-50, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). Likewise, the court can enter judgment in favor of the nonmovant, as long as the court gives “notice and a reasonable time to respond.” Fed.R.Civ.P. 56(f). In this case, both parties agree, and the court FINDS, that there are no material facts in dispute regarding Cree’s alleged infringement of the '026 patent and that Fox cannot meet its burden to prove that Cree infringed the '026 patent under the court’s claim construction. 1 Accordingly, Cree is entitled to judgment as a matter of law on Count One of the Complaint. 2

The only remaining matter is the proper disposition of Cree’s declaratory judgment counterclaims related to the '026 patent. The threshold question is whether this court has subject matter jurisdiction over those counterclaims notwithstanding the fact that Cree is not liable to Fox for infringing the '026 patent. For the court to hear those counterclaims, there must be a “case or controversy” regarding the '026 patent under Article III of the United States Constitution. See 28 U.S.C. § 2201(a) (providing that “[i]n a case or controversy within its jurisdiction, ... any court of the United States ... may declare the rights and other legal relations of any interested party seeking such declaration, whether or not further relief is or could be sought”); Prasco, LLC v. Medicis Pharm. Corp., 537 F.3d 1329, 1335 (Fed.Cir.2008) (explaining that the Declaratory Judgment Act only provides a remedy if the “suit meets the case or controversy requirement of Article III” (citations omitted)). “For there to be a case or controversy ... the dispute must be ‘definite and concrete, touching the legal relations of parties having adverse legal interests,’ ‘real and substantial,’ and ‘admi[t] of spe *523 cific relief through a decree of a conclusive character, as distinguished from an opinion advising what the law would be upon a hypothetical state of facts.’ ” Id. at 1335-36 (quoting MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118, 127, 127 S.Ct. 764, 166 L.Ed.2d 604 (2007)). The test is “whether the facts alleged, under all the circumstances, show that there is a substantial controversy, between parties having adverse legal interests, or sufficient immediacy and reality to warrant the issuance of a declaratory judgment.” Id. at 1336 (internal quotation marks and citations omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

FOX GROUP, INC. v. Cree, Inc., 819 F. Supp. 2d 520, 2011 U.S. Dist. LEXIS 79019, 2011 WL 2963580 (E.D. Va. 2011).

819 F. Supp. 2d 520 (FOX GROUP, INC. v. Cree, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Fox Group, Inc. v. Cree, Inc.
819 F. Supp. 2d 524 (E.D. Virginia, 2011)